NEW
YORK, July 11, 2024 /PRNewswire/ -- ProofPilot,
a leading Clinical Experience Platform (CXP), announced the closing
of its Series C financing, led by Sopris Capital with Mitsui &
Co. (U.S.A.), Inc. participating.
"Much of the focus in clinical trial technology has been on data
capture and AI, but supporting the clinical trial experience for
stakeholders has taken a backseat," said Chris Venezia, CEO of ProofPilot. "Our strategic
advisory board, comprising patients, research sites, and sponsors,
is solving the right challenges and needs to modernize experiences
for all stakeholders. This repeat investment from our Series B
investors recognizes the market's need and provides us with
resources to scale and accelerate life-saving therapies."
ProofPilot's platform, StudyCoPilot, centralizes and simplifies
communication for sponsors, patients, and sites across the clinical
trial experience. The products and services support key initiatives
like improving DE&I, streamlining recruitment & retention,
and easing site burden. ProofPilot has scaled its capabilities for
enterprise use and has industry leading pharmaceutical clients
deploying StudyCoPilot globally.
"The sky is the limit with ProofPilot, and we are excited about
investing in the company. We have tremendous confidence in the team
and are proud to see some of the world's leading life sciences
companies adopt the technology," said Abinav Sankar, Partner at
Sopris Capital.
About ProofPilot
ProofPilot enhances clinical trials with its Clinical Experience
Platform (CXP). The StudyCoPilot platform centralizes and
simplifies communication for sponsors, patients, and sites across
the clinical trial experience. Learn more at:
https://www.proofpilot.com.
About Sopris Capital
Sopris Capital invests growth equity in technology-enabled
business services and SaaS companies solving critical pain points.
Sopris partners with fast-growing companies with a validated
business model, proven product/market fit, and a strong management
team. Learn more at: http://www.sopriscapital.com.
About Mitsui
Mitsui & Co. (U.S.A.), Inc. ("Mitsui USA"), a subsidiary of Mitsui & Co., Ltd.,
Tokyo, Japan, is one of the most
diversified trading, investment, and service enterprises globally.
Mitsui & Co. pursues "360° business innovation" across product
sales, logistics, financing, and major international infrastructure
projects. More information on Mitsui USA can be found at www.mitsui.com/us.
Media Contacts: Colleen Yang,
colleen@proofpilot.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/proofpilot-announces-series-c-funding-302194206.html
SOURCE ProofPilot